Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey

BMC Infect Dis. 2011 Nov 7:11:313. doi: 10.1186/1471-2334-11-313.

Abstract

Background: During the 2009 influenza A/H1N1v pandemic, children were identified as a specific "at risk" group. We conducted a multicentric study to describe pattern of influenza A/H1N1v infection among hospitalized children in Brussels, Belgium.

Methods: From July 1, 2009, to January 31, 2010, we collected epidemiological and clinical data of all proven (positive H1N1v PCR) and probable (positive influenza A antigen or culture) pediatric cases of influenza A/H1N1v infections, hospitalized in four tertiary centers.

Results: During the epidemic period, an excess of 18% of pediatric outpatients and emergency department visits was registered. 215 children were hospitalized with proven/probable influenza A/H1N1v infection. Median age was 31 months. 47% had ≥ 1 comorbid conditions. Febrile respiratory illness was the most common presentation. 36% presented with initial gastrointestinal symptoms and 10% with neurological manifestations. 34% had pneumonia. Only 24% of the patients received oseltamivir but 57% received antibiotics. 10% of children were admitted to PICU, seven of whom with ARDS. Case fatality-rate was 5/215 (2%), concerning only children suffering from chronic neurological disorders. Children over 2 years of age showed a higher propensity to be admitted to PICU (16% vs 1%, p = 0.002) and a higher mortality rate (4% vs 0%, p = 0.06). Infants less than 3 months old showed a milder course of infection, with few respiratory and neurological complications.

Conclusion: Although influenza A/H1N1v infections were generally self-limited, pediatric burden of disease was significant. Compared to other countries experiencing different health care systems, our Belgian cohort was younger and received less frequently antiviral therapy; disease course and mortality were however similar.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Age Distribution
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Belgium / epidemiology
  • Child
  • Child, Hospitalized
  • Child, Preschool
  • Critical Care / statistics & numerical data
  • Female
  • Gastrointestinal Diseases / diagnosis
  • Gastrointestinal Diseases / drug therapy
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Diseases / pathology
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza, Human / complications
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology*
  • Influenza, Human / pathology*
  • Male
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / drug therapy
  • Nervous System Diseases / epidemiology
  • Nervous System Diseases / pathology
  • Oseltamivir / therapeutic use
  • Pandemics*
  • Respiratory Tract Diseases / diagnosis
  • Respiratory Tract Diseases / drug therapy
  • Respiratory Tract Diseases / epidemiology
  • Respiratory Tract Diseases / pathology
  • Survival Analysis

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Oseltamivir